tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CERO Stock Latest News

Cero Therapeutics’ Innovative AML Treatment Study: A Potential Game-Changer?
Company AnnouncementsCero Therapeutics’ Innovative AML Treatment Study: A Potential Game-Changer?
23h ago
CERO
Cero announces third dose for patients in Phase 1 trial of CER-1236
PremiumThe Fly
Cero announces third dose for patients in Phase 1 trial of CER-1236
7d ago
CERO
CERo Therapeutics Expands Securities Purchase Agreement
PremiumCompany Announcements
CERo Therapeutics Expands Securities Purchase Agreement
12d ago
8K
CERO
CERo Therapeutics Enters Securities Purchase Agreement
PremiumCompany Announcements
CERo Therapeutics Enters Securities Purchase Agreement
14d ago
8K
CERO
Cero Therapeutics completes first cohort of Phase 1 trial of CER-1236 in AML
PremiumThe Fly
Cero Therapeutics completes first cohort of Phase 1 trial of CER-1236 in AML
15d ago
CERO
Cero Therapeutics ‘open’ to takeover bids, Axios reports
PremiumThe FlyCero Therapeutics ‘open’ to takeover bids, Axios reports
18d ago
CERO
CERo Therapeutics Updates Corporate Presentation on Innovations
Premium
Company Announcements
CERo Therapeutics Updates Corporate Presentation on Innovations
1M ago
8K
CERO
Cero doses third patient in starting dose cohort of Phase 1 CER-1236 trial
Premium
The Fly
Cero doses third patient in starting dose cohort of Phase 1 CER-1236 trial
1M ago
CERO
Cero Therapeutics receives notice of allowance from USPTO for CER-1236
PremiumThe Fly
Cero Therapeutics receives notice of allowance from USPTO for CER-1236
2M ago
CERO
Cero Therapeutics announces dose intensification in Phase 1 study of CER-1236
PremiumThe Fly
Cero Therapeutics announces dose intensification in Phase 1 study of CER-1236
2M ago
CERO
CERo Therapeutics Gains Fast Track for AML Drug
PremiumCompany Announcements
CERo Therapeutics Gains Fast Track for AML Drug
2M ago
8K
CERO
Cero Therapeutics receives FDA Fast Track designation for CER-1236
PremiumThe Fly
Cero Therapeutics receives FDA Fast Track designation for CER-1236
2M ago
CERO
CERo Therapeutics Faces Nasdaq Delisting Risk
PremiumCompany AnnouncementsCERo Therapeutics Faces Nasdaq Delisting Risk
2M ago
8K
CERO
CERo Therapeutics Delays 10-Q Filing Amid Valuation Issues
Premium
Company Announcements
CERo Therapeutics Delays 10-Q Filing Amid Valuation Issues
2M ago
CERO
Cero Therapeutics files to sell 9.62M shares of common stock for holders
Premium
The Fly
Cero Therapeutics files to sell 9.62M shares of common stock for holders
3M ago
CERO
Cero Therapeutics doses second patient in Phase 1 CER-1236 trial
PremiumThe Fly
Cero Therapeutics doses second patient in Phase 1 CER-1236 trial
3M ago
CERO
Cero Therapeutics files to sell 12.5M shares of common stock for holders
PremiumThe Fly
Cero Therapeutics files to sell 12.5M shares of common stock for holders
3M ago
CERO
CERo Therapeutics Completes Series D Stock Sale
PremiumCompany Announcements
CERo Therapeutics Completes Series D Stock Sale
3M ago
8K
CERO
CERo Therapeutics Enters New Stock Purchase Agreement
PremiumCompany Announcements
CERo Therapeutics Enters New Stock Purchase Agreement
4M ago
8K
CERO
CERo Therapeutics Regains Nasdaq Compliance by July 2025
PremiumCompany AnnouncementsCERo Therapeutics Regains Nasdaq Compliance by July 2025
4M ago
8K
CERO
CERo Therapeutics Completes Additional Series D Funding
Premium
Company Announcements
CERo Therapeutics Completes Additional Series D Funding
4M ago
8K
CERO
Cero Therapeutics upgraded to Buy from Hold at D. Boral Capital
Premium
The Fly
Cero Therapeutics upgraded to Buy from Hold at D. Boral Capital
4M ago
CERO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >